Medical Device Sales Salary Report 2026 — RepPath
Medical device sales total compensation in 2026 ranges from $90,000 for first-year associate reps to $500,000+ for top-decile senior reps in surgical robotics and structural heart. The variance is driven by company, division, specialty, tenure, and territory. This report breaks the numbers down by every dimension that matters.
Compiled by Joe Licata, Founder of RepPath Academy. 20+ years in medical device and pharmaceutical sales at Boston Scientific and Baxter Healthcare. Numbers reflect 2026 compensation data calibrated against MedReps' Annual Medical Sales Salary Report, Glassdoor, LinkedIn Salary, BLS data, and direct industry interviews.
Quick navigation
2026 medical device sales salary at a glance
Across the industry, a typical full-cycle medical device rep earns $80K-$115K base with $180K-$260K OTE. Top-decile performers in spine, structural heart, electrophysiology, and surgical robotics regularly clear $400K, with the highest individual contributors at Intuitive Surgical, Edwards Lifesciences, and J&J MedTech's Abiomed division reaching $500K+ on full quota years.
Pharmaceutical sales runs flatter and lower. Specialty and rare-disease reps at Lilly, Regeneron, BMS, Vertex, and Jazz earn $170K-$240K OTE with top performers in oncology and rare disease clearing $300K. Primary-care pharma compensation tops out around $200K-$220K for top earners.
Capital equipment compensation skews higher on base salary and lower on commission percentage than device. The trade-off: 6-to-24-month sales cycles. Top-performing imaging and robotics reps clear $350K, with senior national-account reps at GE HealthCare and Siemens Healthineers exceeding $400K.
Diagnostics splits into two distinct lanes. Lab and IVD diagnostics at Roche, Abbott, Beckman, and Sysmex pays $150K-$220K OTE. Genomics and precision medicine at Guardant, Natera, Illumina, and Exact Sciences typically pays 30-50% more, with $230K-$330K OTE and top-decile reps clearing $400K.
Medical device sales salary by company (2026)
Compensation varies more by division than by company. A spine rep at Stryker earns dramatically more than an endoscopy rep at the same company. Structural heart at Edwards or Boston Scientific ranks among the highest-paying lanes in the industry.
| Company | Division | Base | OTE | Top Performer |
|---|---|---|---|---|
| Stryker | Orthopedic Reconstruction | $80K-$110K | $180K-$260K | Top decile $400K+ |
| Stryker | Spine | $90K-$120K | $200K-$300K | Top decile $450K+ |
| Stryker | Mako Robotics | $95K-$130K | $220K-$320K | Top decile $400K+ |
| Stryker | Endoscopy | $85K-$115K | $180K-$260K | Top decile $350K+ |
| Stryker | Trauma & Extremities | $85K-$115K | $180K-$270K | Top decile $370K+ |
| Medtronic | Cardiac Rhythm Management | $90K-$125K | $200K-$290K | Top decile $400K+ |
| Medtronic | Neurovascular | $95K-$130K | $220K-$310K | Top decile $400K+ |
| Medtronic | Structural Heart | $95K-$130K | $220K-$310K | Top decile $450K+ |
| Medtronic | Diabetes | $80K-$105K | $160K-$230K | Top performers $280K |
| Medtronic | Surgical Robotics (Hugo) | $90K-$120K | $200K-$290K | Top decile $380K |
| J&J MedTech | DePuy Synthes (Ortho/Spine) | $85K-$115K | $180K-$260K | Top decile $380K |
| J&J MedTech | Ethicon (Surgical) | $80K-$110K | $170K-$250K | Top decile $350K |
| J&J MedTech | Biosense Webster (EP) | $100K-$140K | $230K-$340K | Top decile $450K+ |
| J&J MedTech | Abiomed (Heart Pumps) | $110K-$145K | $250K-$360K | Top decile $500K+ |
| Boston Scientific | Structural Heart | $95K-$130K | $220K-$310K | Top decile $400K+ |
| Boston Scientific | Electrophysiology | $100K-$135K | $220K-$320K | Top decile $420K+ |
| Boston Scientific | Endoscopy | $80K-$110K | $170K-$240K | Top decile $320K |
| Boston Scientific | Urology/Pelvic Health | $80K-$110K | $170K-$250K | Top decile $330K |
| Abbott | Structural Heart | $95K-$125K | $215K-$310K | Top decile $400K+ |
| Abbott | Electrophysiology | $100K-$135K | $220K-$320K | Top decile $420K+ |
| Abbott | Vascular | $85K-$115K | $190K-$280K | Top decile $360K |
| Edwards Lifesciences | Structural Heart (TAVR) | $100K-$140K | $230K-$340K | Top decile $480K+ |
| Intuitive Surgical | da Vinci Robotics | $110K-$150K | $260K-$380K | Top decile $550K+ |
| Zimmer Biomet | Joint Reconstruction | $80K-$110K | $170K-$250K | Top decile $360K |
| Zimmer Biomet | Trauma | $85K-$115K | $180K-$260K | Top decile $380K |
| Smith+Nephew | Joint Reconstruction | $80K-$105K | $170K-$240K | Top decile $340K |
| Arthrex | Sports Medicine | $80K-$110K | $180K-$260K | Top decile $360K |
| Olympus | Endoscopy | $75K-$100K | $150K-$220K | Top decile $300K |
| Hologic | Women's Health | $80K-$105K | $160K-$240K | Top decile $310K |
Top-performer figures describe top-decile earners on full-quota years, not averages. Individual comp varies materially by territory, account ownership, and tenure.
Pharmaceutical sales salary by company (2026)
Pharma comp curves flatter than device. The best earners are concentrated in oncology, immunology, rare disease, and other specialty therapeutic areas. Primary-care territories pay reliably but cap lower than specialty.
| Company | Division/Therapeutic Area | Base | OTE | Top Performer |
|---|---|---|---|---|
| Pfizer | Primary Care | $85K-$105K | $130K-$180K | Top performers $220K |
| Eli Lilly | Specialty (oncology, rare disease) | $90K-$130K | $170K-$240K | Top decile $300K+ |
| Merck | Oncology | $95K-$130K | $180K-$250K | Top decile $310K |
| AbbVie | Specialty (immunology, oncology) | $90K-$125K | $170K-$240K | Top decile $300K |
| Bristol Myers Squibb | Oncology | $95K-$130K | $180K-$250K | Top decile $310K |
| Regeneron | Specialty | $95K-$130K | $180K-$260K | Top decile $320K |
| AstraZeneca | Oncology | $90K-$125K | $170K-$240K | Top decile $290K |
| Novo Nordisk | Diabetes & Obesity | $85K-$110K | $145K-$200K | Top performers $230K |
| GSK | Specialty | $85K-$115K | $155K-$220K | Top performers $260K |
| Sanofi | Specialty | $85K-$115K | $155K-$220K | Top performers $260K |
| Vertex | Rare Disease | $95K-$130K | $185K-$270K | Top decile $320K |
| Jazz Pharmaceuticals | Specialty/Rare Disease | $95K-$130K | $180K-$260K | Top decile $310K |
Capital equipment sales salary by company (2026)
Capital sales pays higher base, lower commission percentage, and runs longer cycles than device. Service-contract trails carry income for years after the equipment sells. Top imaging and robotics reps regularly clear $350K-$400K.
| Company | Segment | Base | OTE | Top Performer |
|---|---|---|---|---|
| GE HealthCare | Imaging (CT, MRI, Ultrasound) | $90K-$125K | $170K-$260K | Top decile $400K+ |
| Siemens Healthineers | Imaging | $95K-$130K | $180K-$280K | Top decile $420K+ |
| Philips | Imaging & Patient Monitoring | $85K-$115K | $160K-$240K | Top decile $360K |
| Canon Medical | Imaging | $80K-$110K | $150K-$220K | Top decile $320K |
| Stryker | Capital Endoscopy | $85K-$115K | $180K-$270K | Top decile $370K |
| Steris | OR Capital & Sterilization | $80K-$110K | $150K-$230K | Top decile $310K |
| Getinge | OR & ICU Capital | $80K-$105K | $145K-$220K | Top decile $300K |
| Karl Storz | Endoscopy Capital | $80K-$110K | $150K-$230K | Top decile $310K |
Diagnostics sales salary by company (2026)
The lab/IVD vs genomics gap is the largest comp split inside any single category in medical sales. A reference-lab rep at Quest or Labcorp earns half what a senior Guardant or Natera rep earns. Career path matters here.
| Company | Segment | Base | OTE | Top Performer |
|---|---|---|---|---|
| Roche Diagnostics | Lab/IVD | $80K-$105K | $150K-$220K | Top decile $290K |
| Abbott Diagnostics | Lab/IVD | $80K-$105K | $150K-$220K | Top decile $290K |
| Beckman Coulter | Lab/IVD | $75K-$100K | $145K-$210K | Top decile $270K |
| Sysmex | Lab/IVD (Hematology) | $75K-$100K | $140K-$200K | Top decile $260K |
| Cepheid (Danaher) | Molecular / Point-of-Care | $85K-$115K | $160K-$240K | Top decile $310K |
| BD (Becton Dickinson) | Molecular / Microbiology | $80K-$110K | $155K-$230K | Top decile $300K |
| Guardant Health | Genomics (Oncology) | $115K-$150K | $230K-$330K | Top decile $400K+ |
| Natera | Genomics (Oncology, Reproductive) | $115K-$150K | $230K-$330K | Top decile $400K+ |
| Exact Sciences | Genomics (Cologuard) | $110K-$140K | $210K-$300K | Top decile $380K |
| Illumina | Genomics Sequencing | $110K-$140K | $200K-$280K | Top decile $360K |
| Tempus | Precision Medicine | $105K-$140K | $200K-$290K | Top decile $370K |
| Quest Diagnostics | Reference Lab | $70K-$95K | $130K-$190K | Top decile $240K |
| Labcorp | Reference Lab | $70K-$95K | $130K-$190K | Top decile $240K |
Medical sales salary by specialty (2026)
Specialty choice is the single biggest comp lever in medical sales. The same skillset across two specialties can produce a 2x to 3x compensation difference. See how RepPath helps candidates pick the right specialty for their background.
| Specialty | Base | OTE | Top Decile |
|---|---|---|---|
| Surgical Robotics | $100K-$140K | $230K-$330K | $500K+ |
| Structural Heart (TAVR / MitraClip / Watchman) | $95K-$130K | $220K-$310K | $450K+ |
| Electrophysiology | $100K-$135K | $220K-$330K | $440K+ |
| Spine | $90K-$120K | $200K-$300K | $450K+ |
| Cardiac Rhythm Management (CRM) | $90K-$125K | $200K-$290K | $400K+ |
| Neurovascular | $95K-$130K | $220K-$310K | $420K+ |
| Genomics Diagnostics (Guardant/Natera/Illumina) | $115K-$150K | $230K-$330K | $400K+ |
| Capital Imaging | $90K-$130K | $170K-$280K | $400K+ |
| Trauma & Extremities | $85K-$115K | $180K-$270K | $370K+ |
| Orthopedic Reconstruction (Joints) | $80K-$110K | $180K-$260K | $360K+ |
| Ortho Sports Medicine | $80K-$110K | $180K-$260K | $360K+ |
| Endoscopy & Surgical Energy | $80K-$110K | $170K-$250K | $340K |
| Specialty/Rare Disease Pharma | $90K-$130K | $170K-$260K | $320K |
| Oncology Pharma | $90K-$130K | $170K-$250K | $310K |
| Lab/IVD Diagnostics | $80K-$105K | $150K-$220K | $290K |
| Diabetes (Device + Pharma) | $80K-$110K | $160K-$230K | $280K |
| Women's Health | $80K-$105K | $160K-$240K | $310K |
| Primary Care Pharma | $85K-$105K | $130K-$180K | $220K |
Salary by role tier (2026)
Tenure matters, but the bigger driver is the move from associate to full rep, and from full rep to specialty or senior. Associate programs typically run 18-24 months at capital companies, 6-12 months at most device companies, before graduating into a full rep role with a real territory.
| Role Tier | Tenure | Base | OTE | Top Decile |
|---|---|---|---|---|
| Associate Sales Representative | 0-2 yrs | $55K-$80K | $90K-$130K | $150K |
| Full Sales Representative | 2-7 yrs | $80K-$115K | $180K-$260K | $360K+ |
| Senior Sales Representative | 7+ yrs | $100K-$140K | $230K-$340K | $480K+ |
| Specialty / National Account Rep | 5+ yrs | $115K-$150K | $260K-$380K | $500K+ |
| Regional / District Sales Manager | 8+ yrs | $130K-$170K | $240K-$340K | $400K+ |
| Area Vice President / Director | 12+ yrs | $170K-$240K | $320K-$480K | $650K+ |
Methodology & sources
The ranges in this report represent 2026 total compensation including base salary, on-target commissions, bonuses, and stock or equity where applicable. They are calibrated against the following sources:
- MedReps 2026 Annual Medical Sales Salary Report — primary source for self-reported rep compensation across device, pharma, and diagnostics
- Glassdoor & LinkedIn Salary — aggregated user-reported compensation data, filtered for verified employees and post-2024 reports
- Bureau of Labor Statistics (BLS) — Wholesale and Manufacturing Sales Representatives, Technical and Scientific Products (SOC 41-4011)
- Public company 10-K filings and proxy statements — used to validate executive and senior-rep ranges where disclosed
- Direct industry interviews — RepPath internal data from 2025-2026 placements and current-rep conversations across the industry
Top-performer figures describe top-decile earners on full-quota years, not averages. Actual earnings vary substantially by territory size, account portfolio, tenure, and individual performance. Equity compensation at companies like Intuitive Surgical, Edwards, and Guardant Health can materially exceed base + commission in years of significant stock appreciation; those gains are not included in the ranges above.
How candidates land at the companies paying these numbers
Knowing the comp is the easy part. Landing the role at a company paying the top end is the hard part. Stryker, Medtronic, J&J MedTech, Boston Scientific, Abbott, Edwards, and Intuitive run the most competitive hiring funnels in the industry. Most candidates who target them without coached preparation get filtered out before the panel round.
RepPath is Joe Licata's coaching program. Joe has 20+ years in the industry and has placed candidates into every major medical sales lane: device, pharmaceutical, capital equipment, and diagnostics. Most clients land offers in 9-10 weeks of active execution. Every client has a placement guarantee that runs until they land a role.
Reserve My Spot in RepPath Academy →